Does AMGEN Inc. (AMGN) offer a good opportunity for investors?

With 5.94 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.56 million shares. During the session, the Drug Manufacturers – General company that operates in wider Healthcare sector, reached to the highest price of $297.92 whereas the lowest price it dropped to was $288.78. The 52-week range on AMGN shows that it touched its highest point at $329.72 and its lowest point at $211.71 during that stretch. It currently has a 1-year price target of $309.26. With its current market cap of 157.80 billion, AMGN has annualized dividend of $9.32 while the current yield stands at 3.16%. Beta for the stock currently stands at 0.61.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMGN was down-trending over the past week, with a drop of -9.15%, but this was down by -4.04% over a month. Three-month performance surged to 8.76% while six-month performance rose 13.70%. The stock gained 20.84% in the past year, while it has gained 2.37% so far this year. A look at the trailing 12-month EPS for AMGN yields 12.48 with Next year EPS estimates of 21.35. For the next quarter, that number is 4.04. This implies an EPS growth rate of 5.88% for this year and 8.13% for next year. EPS is expected to grow by 5.29% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -0.21%.

Float and Shares Shorts:

At present, 535.00 million AMGN shares are outstanding with a float of 533.97 million shares on hand for trading. On Jan 11, 2024, short shares totaled 8.84 million, which was 1.65% higher than short shares on Dec 14, 2023. In addition to AMZN as the firm’s, Inc., AMGN serves as its Amgen Inc..

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMGN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMGN analysts setting a high price target of $380.00 and a low target of $215.00, the average target price over the next 12 months is $309.26. Based on these targets, AMGN could surge 28.88% to reach the target high and fall by -27.08% to reach the target low. Reaching the average price target will result in a growth of 4.89% from current levels.

Dividends & Yield:

In terms of dividends, AMGN has a current ratio of $9.0, which is $9.0 over the trailing 12-months, while a dividend of $6.77 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and AMGN currently yields $2.89. In the past year, AMGN’s dividend yield has been $2.89, but when looking at the stock over the past five years, its yield has been $2.96. Accordingly, AMGN has a current buyback yield of $0.0. This was $0.0 for the TTM, and it was $4.72 for the past five years.

Summary of Insider Activity:

Insiders traded AMGN stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 41 while that of sell transactions has risen to 50 over the past year. The total number of shares bought during that period was 117,784 while 77,815 shares were sold.